Abbonarsi

Performance and attitudes toward real-time computer-aided polyp detection during colonoscopy in a large tertiary referral center in the United States - 16/06/23

Doi : 10.1016/j.gie.2023.02.016 
Fredy Nehme, MD , Emmanuel Coronel, MD , Denise A. Barringer, MS, Laura G. Romero, MBA, Mehnaz A. Shafi, MD, William A. Ross, MD, Phillip S. Ge, MD
 Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA 

Reprint requests: Phillip S. Ge, MD, Department of Gastroenterology, Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1466, Houston, TX 77030-4009.Department of GastroenterologyHepatology and NutritionThe University of Texas MD Anderson Cancer CenterUnit 14661515 Holcombe BlvdHoustonTX77030-4009

Abstract

Background and Aims

Computer-aided detection (CADe) has been shown to improve polyp detection in clinical trials. Limited data exist on the impact, utilization, and attitudes toward artificial intelligence (AI)-assisted colonoscopy in daily clinical practice. We aimed to evaluate the effectiveness of the first U.S. Food and Drug Administration–approved CADe device for polyp detection in the United States and the attitudes toward its implementation.

Methods

We performed a retrospective analysis of a prospectively maintained database of patients undergoing colonoscopy at a tertiary center in the United States before and after a real-time CADe system was made available. The decision to activate the CADe system was at the discretion of the endoscopist. An anonymous survey was circulated among endoscopy physicians and staff at the beginning and conclusion of the study period regarding their attitudes toward AI-assisted colonoscopy.

Results

CADe was activated in 52.1% of cases. Compared with historical control subjects, there was no statistically significant difference in adenomas detected per colonoscopy (1.08 vs 1.04, P = .65), even after excluding diagnostic and therapeutic indications and cases where CADe was not activated (1.27 vs 1.17, P = .45). In addition, there was no statistically significant difference in adenoma detection rate (ADR), median procedure, and withdrawal times. Survey results demonstrated mixed attitudes toward AI-assisted colonoscopy, of which main concerns were high number of false-positive signals (82.4%), high level of distraction (58.8%), and impression it prolonged procedure time (47.1%).

Conclusions

CADe did not improve adenoma detection in daily practice among endoscopists with high baseline ADRs. Despite its availability, AI-assisted colonoscopy was only activated in half of the cases, and multiple concerns were raised by staff and endoscopists. Future studies will help elucidate the patients and endoscopists that would benefit most from AI-assisted colonoscopy.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : AI, ADR, APC, CADe, CRC, RCT, SSLDR


Mappa


 DISCLOSURE: The following author disclosed financial relationships: P. S. Ge: Consultant for Alira Health, Boston Scientific, Ovesco America, and Neptune Medical. All other authors disclosed no financial relationships.
 DIVERSITY, EQUITY, AND INCLUSION: We worked to ensure gender balance in the recruitment of human subjects. We worked to ensure that the language of the study questionnaires reflected inclusion. One or more of the authors of this paper self-identifies as an under-represented gender minority in science.


© 2023  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 98 - N° 1

P. 100 - luglio 2023 Ritorno al numero
Articolo precedente Articolo precedente
  • Computer-aided diagnosis of early-stage colorectal cancer using nonmagnified endoscopic white-light images (with videos)
  • Daiki Nemoto, Zhe Guo, Shinichi Katsuki, Takahito Takezawa, Ryo Maemoto, Keisuke Kawasaki, Ken Inoue, Takashi Akutagawa, Hirohito Tanaka, Koichiro Sato, Teppei Omori, Kunihiro Takanashi, Yoshikazu Hayashi, Yuki Nakajima, Yasuyuki Miyakura, Takayuki Matsumoto, Naohisa Yoshida, Motohiro Esaki, Toshio Uraoka, Hiroyuki Kato, Yuji Inoue, Boyuan Peng, Ruiyao Zhang, Takashi Hisabe, Tomoki Matsuda, Hironori Yamamoto, Noriko Tanaka, Alan Kawarai Lefor, Xin Zhu, Kazutomo Togashi
| Articolo seguente Articolo seguente
  • Computer-aided polyp detection (CADe) in real life: not the “CADe-llac” we were promised
  • Fares Ayoub, Neil Sengupta

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.